Skip to main content
GIPResearch.com · Patent and Technology Research

INDIAN INSTITUTE OF TECHNOLOGY, DELHI GRANTED PATENT FOR A BONSAI FORM OF ARCHEAL L-ASPARAGINASE AND USES THEREOF.

Indian Institute of Technology, Delhi was established in the year, 1959 and has grown exponentially ever since.

Save or follow this source
These actions open third-party AI services. Saving, citation, and future recall are not guaranteed.
Conceptual GIPResearch illustration for INDIAN INSTITUTE OF TECHNOLOGY, DELHI GRANTED PATENT FOR A BONSAI FORM OF ARCHEAL L-ASPARAGINASE AND
Research and original publication material

INDIAN INSTITUTE OF TECHNOLOGY, DELHI GRANTED PATENT FOR A BONSAI FORM OF ARCHEAL L-ASPARAGINASE AND USES THEREOF. — research background

Research context: This article preserves existing publication material for continuity. Technical, commercial and legal references should be checked against current primary sources before making decisions.

Indian Institute of Technology, Delhi was established in the year, 1959 and has grown exponentially ever since. The company's field of business ranges from providing academic courses to offering miscellaneous educational services. In India, the business of Indian Institute of Technology, Delhi focuses on methods of analyzing cell membranes, method and system for suppressing noise in speech signals in hearing aids and speech transmission instruments, the system of dough processing polymer-metal blend suitable for shape forming, and catalytic decomposition of lower hydrocarbons to produce carbon oxides free hydrogen and bamboo-shaped carbon nanotubes. Indian Institute of Technology, Delhi filed a patent application numbered 1236/DEL/2014 that is titled as A BONSAI FORM OF ARCHEAL L-ASPARAGINASE AND USES THEREOF. The patent has been filed in the field of Micro Biology. This Patent Application has been granted as Patent Number 353743. This invention relates to recombinant enzymes with superior physicochemical properties compared to their wild type counterpart, and methods for producing the same. The disclosure also provides various uses of the enhanced recombinant enzyme. During the patent examination, the Patent Examiner raised objections under Section 3(d) of the Patents Act, 1970 wherein the subject matter of certain claims disclose a mere practice of known processes/molecules. D1 (US 2013/0330316A1) already discloses the SEQ ID: 3, which is 99.0% similar to SEQ ID: 7 and 100% similar to instant SEQ ID: 8. The cited prior art also discloses the SEQ ID: 8, which is 100% similar to instant SEQ ID: 12 having the same function. As a response, the Applicant submitted that the Controller has wrongly picked the individual sequences from the pending claims for the BLAST searches. The claimed invention lies in the combination of specific polypeptide sequences conjoined together, which is neither disclosed nor mentioned in the cited Document. Hence, the claimed polypeptides resulting from such a conjoining are novel and inventive. Advocate Rahul Dev is a Patent Attorney & International Business Lawyer practicing Technology, Intellectual Property & Corporate Laws. He is reachable at rd (at) patentbusinesslawyer (dot) com & @rdpatentlawyer on Twitter. Quoted in and contributed to 50+ national & international publications (Bloomberg, FirstPost, SwissInfo, Outlook Money, Yahoo News, Times of India, Economic Times, Business Standard, Quartz, Global Legal Post, International Bar Association, LawAsia, BioSpectrum Asia, Digital News Asia, e27, Leaders Speak, Entrepreneur India, VCCircle, AutoTech). Regularly invited to speak at international & national platforms (conferences, TV channels, seminars, corporate trainings, government workshops) on technology, patents, business strategy, legal developments, leadership & management.

Discuss a research question related to INDIAN INSTITUTE OF TECHNOLOGY, DELHI GRANTED PATENT

Describe your objective and the evidence you need. The suitability and scope of any research engagement will be confirmed individually.

Discuss a research question

Source and context: Original GIPResearch.com publication dated 2020-12-29. Existing text is retained for historical continuity. Verify time-sensitive matters using official records.

None

Featured Work & Insights